Gene therapy in the United States: A five-year status report

Human Gene Therapy

Volumn 7, Issue 14, 1996, Pages 1781-1790

  Ross, Gail ^a,h   Erickson, Robert ^b,h   Knorr, Debra ^c   Motulsky, Arno G ^d,h   Parkman, Robertson ^e,h   Samulski, Jude ^f,h   Straus, Stephen E ^c,h   Smith, Brian R ^g,h  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NIH Recombinant DNA Advsy Committee

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT DNA;

ADENOVIRUS; BIOTECHNOLOGY; BONE MARROW TRANSPLANTATION; CELL TYPE; CLINICAL PROTOCOL; CLINICAL TRIAL; EXPRESSION VECTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; MARKER GENE; PATHOGENESIS; RETROVIRUS; REVIEW; SAFETY; STEM CELL; TREATMENT OUTCOME; UNITED STATES; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0029799638     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.14-1781     Document Type: Review

References (28)

1. BLAESE, R.M., CULVER, K.W., MILLER, A.D., CARTER, C.S., FLEISHER, T., CLERICI, M., SHEARER, G., CHANG, L., CHIANG, Y., TOLSTOSHEV, P., GREENBLATT, J.J., ROSENBERG, S.A., KLEIN, H., BERGER, M., MULLEN, C.A., RAMSEY, W.J., MUUL, L., MORGAN, R.A., and ANDERSON, W.F. (1995). T-lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270, 475-480.
2. BRENNER, M.K., RILL, D.R., and MOEN, R.C. (1993a). Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341, 85-86.
3. BRENNER, M.K., RILL, D.R., and HOLLADAY, M.S. (1993b). Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342, 1134-1137.
4. BROWN, M.S., GOLDSTEIN, J.L., HAVEL, R.J., and STEINBERG, D. (1994). Gene therapy for cholesterol. Nature Genet. 7, 349-350.
5. CAI, Q., RUBIN, J.T., and LOTZE, M.T. (1996). Genetically marking human cells - results of the first clinical gene transfer studies. Cancer Gene Ther. 2, 125-136.
6. CORNETTA, K., SROUR, E.F., and DEREBITSKY, D. (1994). Retroviral marking of autologous bone marrow grafts in adult acute leukemia. Blood 84, Suppl. 1, 1591.
7. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
8. DEISSEROTH, A.B., ZU, Z., CLAXTON, D., HANANIA, E.G., FU, S., ELLERSON, D., GOLDBERG, L., THOMAS, M., JANICEK, K., ANDERSON, W.F., HESTER, J., KORBLING, M., DURETT, A., MOEN, R., BERENSON, R., HEIMFELD, S., HAMER, J., CALVERT, L., TIBBITS, P., TALPAZ, M., KANTARJIAN, H., CHAMPLIN, R., and READING, C. (1994). Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83, 3068-3076.
9. DODGE, J.A. (1995). IL-6 release and air-way administration of human CFTR cDNA adenovirus vector. Nature Med. 1, 182-184.
10. DUNBAR, C.E., COTTLER-FOX, M., O'SHAUGHNESSY, J.A., DOREN, S., CARTER, C., BERENSON, R., BROWN, S., MOEN, R.C., GREENBLATT, J., STEWART, F.M., LEITMAN, S.F., WILSON, W.H., COWAN, K., YOUNG, N.S., and NIENHUIS, A.W. (1995). Retrovirally-marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplatation. Blood 85, 3048-3057.
11. GROSSMAN, M., RAPER, S.E., KOZARSKY, K., STEIN, E.A., ENGELHARDT, J.F., MULLER, D., LUPIEN, P.J., and WILSON, J.M. (1994). Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature Genet. 6, 337-341.
12. GROSSMAN, M., RADER, D.J., MULLER, D.W., KOLANSKY, D.M., KOZARSKY, K., CLARK, B.J., 3RD, STEIN, E.A., LUPIEN, P.J., BREWER, H.B., JR., RAPER, S.E., et al. (1995). A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nature Med. 1, 1148-1154.
13. HERSH, E.M., AKPORIAYE, E., HARRIS, D., STOPECK, A.T., UNGER, E.C., WARNEKE, J.A., and KRADJIAN, S.A. (1994). Phase I study of immunotherapy of maligant melanoma by direct gene transfer. Hum. Gene Ther. 5, 1371-1384.
14. KNOWLES, M.R., HOHNEKER, K.W., ZHOU, Z., OLSEN, J.C., NOAH, T.L., HU, P.C., LEIGH, M.W., ENGELHARDT, J.F., EDWARDS, L.J., JONES, K.R., GROSSMAN, M., WILSON, J.M., JOHNSON, L.G., and BOUCHER, R.C. (1995). A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patient with cystic fibrosis. N. Engl. J. Med 333, 823-831.
15. KOHN, D.B. (1995). The current status of gene therapy using hematopoietic stem cells. [Review]. Curr. Opin. Pediatr. 7, 56-63.
16. KOHN, D.B., WEINBERG, K.I., NOLTA, J.A., HEISS, L.N., LENARSKY, C., CROOKS, G.M., HANLEY, M.E., ANNETT, G., BROOKS, J.S., EL-KHOUREIY, A., et al. (1995). Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med. 1, 1017-1023.
17. MARCEL, T., and GRAUSZ, J.D. (1995). Worldwide Gene Therapy Clinical Trial Enrollment Status. (TMC Development, Paris, France).
18. NABEL, E.G., YANG, Z., MULLER, D., CHANG, A.E., GAO, X., HUANG, L., CHO, K.J., and NABEL, G.J. (1994). Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastic melanoma. Hum. Gene Ther. 5, 1089-1094.
19. NABEL, G.J., NABEL, E.G., YANG, Z.Y., FOX, B.A., PLAUTZ, G.E., GAO, X., HUANG, L., SHU, S., GORDON, D., and CHANG, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. 90, 11307-112311.
20. ORKIN, S.U., and MOTULSKY, A.G. (Co-Chairmen). (Dec. 1995). Report and recommendations of the panel to assess the NIH investment in research on gene therapy. National Institutes of Health USA, World Wide Web: http//www.nih.gov/news/panelrep.html., pp. 1-49.
21. RAPER, S.E., GROSSMAN, M., RADER, D.J., THOENE, J.G., CLARK, B.J., 3RD, KOLANSKY, D.M., MULLER, D.W., and WILSON, J.M. (1996). Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann. Surg. 223, 116-126.
22. Recombinant DNA Advisory Committee (RAC). Minutes of Meeting, June 8-9, 1995. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD.
23. RILL, D.R., SANTANA, V.M., ROBERTS, W.M., NILSON, T., BOWMAN, L.C., KRANCE, R.A., HESLOP, H.E., MOEN, R.C., IHLE, J.N., and BRENNER, M.K. (1994). Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84, 380-383.
24. ROONEY, C.M., SMITH, C.A., NG, C.Y.C., LOFTIN, S., LI, C., KRANCE, R.A., BRENNER, M.K., and HESLOP, H.E. (1995). Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345, 9-13.
25. ROSENBERG, S.A., AEBERSOLD, P., CORNETTA, K., KASID, A., MORGAN, R.A., MOEN, R., KARSON, E.M., LOTZE, M.T., YANG, J.C., TOPALIAN, S.L., MERINO, M.J., CULVER, K., MILLER, A.D., BLAESE, R.M., and ANDERSON, W.F. (1990). Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. Med. 323, 570-578.
26. ROSENBERG, S.A., LOTZE, M.T., YANG, J.C., TOPALIAN, S.L., CHANG, A.E., SCHWARTZENTRUBER, D.J., AEBERSOLD, P., LEITMAN, S., LINEHAN, W.M., SEIPP, C.A., WHITE, D.E., and STEINBERG, S.M. (1993). Prospective randomized trial if high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer [published erratum appears in J. Natl. Cancer Inst. (1993) 85, 1091]. J. Natl. Cancer Inst. 85, 622-632.
27. WALTER, H.A., GREENBERG, P.D., GILBERT, M.J., FINCH, R.J., WATANABE, K.S., THOMAS, E.D., and RIDDELL, S.R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044.
28. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.